Stage IIA Fallopian Tube Cancer

9 clinical trials · Condition

Record	Firm	Date
Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02833506)	Roswell Park Cancer Institute	2017-12-08
Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer (NCT01536054)	Roswell Park Cancer Institute	2012-08-20
Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer (NCT01275664)	Gynecologic Oncology Group	2011-06-01
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer (NCT01764802)	Ohio State University Comprehensive Cancer Center	2010-10-01
OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission (NCT00857545)	Gynecologic Oncology Group	2010-07-01
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy (NCT01080521)	Gynecologic Oncology Group	2010-04-01
Collecting Tumor Samples From Patients With Gynecological Tumors (NCT00897442)	Gynecologic Oncology Group	1992-06-01

Every clearance here is in the API, with alerts when new ones post.